- Maximum flexibility for microbial and cell culture applications
- Intuitive operation; user-friendly design
Goettingen, July 17, 2012 – Sartorius Stedim Biotech (SSB), a leading international pharma and biotech provider, is bringing a completely revamped generation of its successful bioreactor series out on the market: BIOSTAT® B. This autoclavable fermentor / bioreactor has been specially designed to cover the wide variety of requirements in biotechnological and biopharmaceutical research and development. BIOSTAT® B can be supplied as a flexible basic unit for preclinical research on up to a ready-configured, fully qualified bioreactor system that meets the requirements of a validated GMP environment.
Flexible system for cell cultivation and microbial fermentation
BIOSTAT® B is a modular-designed system. Its control unit is available as a single or twin version and can thus control up to two culture vessels simultaneously and independently. For the vessels, users can opt for two-liter, single-use polycarbonate bioreactors or reusable stirred glass bioreactors with volumes of one, two, five or ten liters, depending on their needs.
The BIOSTAT® B system is suitable for both microbial fermentation and cell cultivation applications.
Intuitive operation; user-friendly design
New functions and an especially user-friendly design make working with the bioreactor even easier. The color 12-inch touch-screen display guides users easily and intuitively through the menu. Among the new functions, a gravimetric controller that uses a high-capacity balance as well as an rpm-controlled pump help ensure that substrates are accurately dispensed. Laboratory staff can adjust the feed rate directly on the control unit display, which eliminates the need for external software. Quick-connect couplings make it fast and simple to connect the culture vessels to the control unit. A potential-free alarm contact shields the BIOSTAT® B from electromagnetic currents, ensuring interference-free measurements during cultivation processes.
Current Image Files
http://www.sartorius.com/fileadmin/media/global/company/biostat_b_application.jpg
BIOSTAT B – the all-arounder for microbial and cell culture applications
http://www.sartorius.com/fileadmin/media/global/company/biostat_b_twin_version.jpg
One control unit, two vessels – the BIOSTAT B as a twin version
About Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions.” Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs approx. 2,850 people, and in 2011 earned sales revenue of 477.,3 million euros.
Contacts for Sartorius Stedim Biotech
Karin Gaisböck
Group Corporate Communications
+49 (0)551 308 3615
[email protected]
Dominic Grone
Group Corporate Communications
+49 (0)551 308 3324
[email protected]